Sulfonamide cannabinoid agonists and antagonists

Billy R Martin (Inventor), Raj K Razdan (Inventor), Roger Guy Pertwee (Inventor)

Research output: Patent

Abstract

Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.
Original languageEnglish
Patent numberUS2005096379
IPCC07D311/80; C07D311/00
Publication statusPublished - 5 May 2005

Fingerprint

Cannabinoid Receptor Antagonists
Cannabinoid Receptor Agonists
Sulfonamides
Cannabinoids
Acute Pain
Appetite
Chronic Pain
Nausea
Multiple Sclerosis
Vomiting
Seizures
Inflammation
Therapeutics

Cite this

Martin, B. R., Razdan, R. K., & Pertwee, R. G. (2005). IPC No. C07D311/80; C07D311/00. Sulfonamide cannabinoid agonists and antagonists. (Patent No. US2005096379).

Sulfonamide cannabinoid agonists and antagonists. / Martin, Billy R (Inventor); Razdan, Raj K (Inventor); Pertwee, Roger Guy (Inventor).

IPC No.: C07D311/80; C07D311/00. Patent No.: US2005096379.

Research output: Patent

Martin, BR, Razdan, RK & Pertwee, RG 2005, Sulfonamide cannabinoid agonists and antagonists, Patent No. US2005096379, IPC No. C07D311/80; C07D311/00.
Martin BR, Razdan RK, Pertwee RG, inventors. Sulfonamide cannabinoid agonists and antagonists. C07D311/80; C07D311/00. 2005 May 5.
Martin, Billy R (Inventor) ; Razdan, Raj K (Inventor) ; Pertwee, Roger Guy (Inventor). / Sulfonamide cannabinoid agonists and antagonists. IPC No.: C07D311/80; C07D311/00. Patent No.: US2005096379.
@misc{cf43380f376e441a8fec65a263d6b266,
title = "Sulfonamide cannabinoid agonists and antagonists",
abstract = "Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.",
author = "Martin, {Billy R} and Razdan, {Raj K} and Pertwee, {Roger Guy}",
year = "2005",
month = "5",
day = "5",
language = "English",
type = "Patent",
note = "US2005096379; C07D311/80; C07D311/00",

}

TY - PAT

T1 - Sulfonamide cannabinoid agonists and antagonists

AU - Martin, Billy R

AU - Razdan, Raj K

AU - Pertwee, Roger Guy

PY - 2005/5/5

Y1 - 2005/5/5

N2 - Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.

AB - Cannabinoid agonists and antagonists are provided for use in the treatment of disorders such as acute and chronic pain, inflammation, loss of appetite, convulsions, multiple sclerosis, nausea and vomiting. The cannabinoid agonists and antagonists contain a sulfonamide moiety incorporated into the cannabinoid side chain, and the side chain itself may be saturated or unsaturated.

M3 - Patent

M1 - US2005096379

ER -